Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « A. M. Bonnet »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
A. Lees < A. M. Bonnet < A. Marques Gomes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000510 (2001) Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
000553 (1999) M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
000592 (1997) A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
000625 (1995) A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
000663 (1991) Jedynak [France] ; A. M. Bonnet [France] ; Yves Agid [France]Tremor and idiopathic dystonia
000667 (1991) C. P. Jedynak ; A. M. Bonnet ; Yves Agid [France]Tremor and idiopathic dystonia
000678 (1987) A. M. Bonnet [France] ; Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire [France] ; Y. De Smet [France] ; Yves Agid [France]Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea

List of associated KwdEn.i

Nombre de
documents		Descripteur
6Human
5Parkinson disease
3Aged
3Female
3Humans
3Male
3Middle Aged
2Adult
2Antiparkinson Agents (adverse effects)
2Antiparkinson agent
2Dose-Response Relationship, Drug
2Dyskinesia
2Electromyography
2Levodopa
2Levodopa (adverse effects)
2Nervous system diseases
2Parkinson Disease (drug therapy)
2Parkinson's disease
2Treatment
2Tremor
1Administration, Oral
1Adolescent
1Adrenergic alpha-Antagonists (adverse effects)
1Adrenergic alpha-Antagonists (therapeutic use)
1Agonist
1Aminoacid
1Animals
1Antagonist
1Antiparkinson Agents (therapeutic use)
1Biochemistry
1Bromocryptine
1Carnosine (analogs & derivatives)
1Carnosine (cerebrospinal fluid)
1Cerebrospinal fluid
1Chemotherapy
1Classification
1Comparative study
1Corpus striatum
1Degeneration
1Degenerative disease
1Diagnosis, Differential
1Dipeptides (cerebrospinal fluid)
1Dopamine
1Dyskinesia, Drug-Induced (diagnosis)
1Dyskinesia, Drug-Induced (drug therapy)
1Dyskinesia, Drug-Induced (etiology)
1Dystonia
1Dystonia (complications)
1Dystonia (diagnosis)
1Dystonia (physiopathology)
1Electrodiagnosis
1Exploration
1Friedreich Ataxia (cerebrospinal fluid)
1Friedreich ataxia
1Friedreich's ataxia
1GABA
1Haplorhini
1Heredodegeneration
1Homocarnosine
1Huntington Disease (cerebrospinal fluid)
1Huntington disease
1Huntington's chorea
1Idazoxan
1Idazoxan (adverse effects)
1Idazoxan (therapeutic use)
1Idiopathic dystonia
1Involuntary movement
1Levodopa (pharmacology)
1Levodopa (therapeutic use)
1L‐DOPA, dyskinesia
1Muscle Contraction
1Muscle Relaxation
1Myoclonus (diagnosis)
1Myoclonus (physiopathology)
1Neurologic Examination (drug effects)
1Nigrostriatal pathway
1Parkinson Disease (cerebrospinal fluid)
1Performance evaluation
1Periodicity
1Phase II trial
1Phenomenology
1Pilot Projects
1Severity of Illness Index
1Striated muscle
1Symptomatology
1Test
1Toxicity
1Tremor (complications)
1Tremor (diagnosis)
1Tremor (physiopathology)
1Voiding dysfunction
1gamma-Aminobutyric Acid (cerebrospinal fluid)
1idazoxan
1α2 receptors
1α2-Adrenergic receptor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "A. M. Bonnet" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "A. M. Bonnet" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    A. M. Bonnet
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024